Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion
about
The contribution of prostaglandins versus prostacyclin in ventricular remodeling during heart failureAn Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and DiseasesDistinct roles of central and peripheral prostaglandin E2 and EP subtypes in blood pressure regulationFractalkine depresses cardiomyocyte contractilityFolic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.Cardiovascular biology of microsomal prostaglandin E synthase-1.Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.Fractalkine neutralization improves cardiac function after myocardial infarction.Fatty acids and cardiac disease: fuel carrying a message.Increased 4-hydroxy-2-nonenal-induced proteasome dysfunction is correlated with cardiac damage in streptozotocin-injected rats with isoproterenol infusion.Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in miceAngiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice.Renal effects induced by prolonged mPGES1 inhibition.Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.Knockout of the Prostaglandin E2 Receptor Subtype 3 Promotes Eccentric Cardiac Hypertrophy and Fibrosis in Mice.Inflammation leads through PGE/EP3 signaling to HDAC5/MEF2-dependent transcription in cardiac myocytes.
P2860
Q26830372-1E5D1626-5C90-45C3-8F1F-09386DD7AE0FQ28067884-4057D149-FA3D-4259-BE02-F9CC1105BA59Q34281269-5D0059AB-53C6-4412-9DC2-5BE8381C28F2Q34921351-DFF5D125-759B-4F71-BED5-410B1E683DF2Q35080666-22F23816-8FBB-4EDF-AD7B-76EB586F06D3Q35607129-45AECB3E-0761-46E0-8BFC-CDBE6E45FEA5Q35889735-6E1EC747-6E5C-40F8-BDBF-FABE00120A3CQ35961854-8CB3DDCC-3B2F-4FEE-94AB-4936999FB1E7Q36390463-E01C7841-F51A-422F-A3DA-26329E9EB15EQ38207743-89CCC06B-DB5B-47B9-B9C0-0087D92B3BF7Q38765976-0AEDFE6D-4E6E-4583-9A77-2DE1601BC52EQ39357418-A994BB20-2DB7-49CA-9163-89F603DDA387Q40344427-FD04B5FA-F0C7-40F9-9BF9-9BC819417974Q44020805-F939931B-C972-442A-8FD1-42FECDA654E3Q51742158-36509A11-8B48-4591-8883-1A62F979EF36Q54199502-B6883CAC-646F-4FB8-BA0E-1A93C06A68F0Q55625734-C10F405D-25F0-4243-8FCE-10AAF0EAB148
P2860
Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@ast
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@en
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@nl
type
label
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@ast
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@en
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@nl
prefLabel
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@ast
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@en
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@nl
P2093
P2860
P1476
Lack of microsomal prostagland ...... lowing angiotensin II infusion
@en
P2093
Margot C Lapointe
Pamela Harding
Xiao-Ping Yang
P2860
P304
P356
10.1152/AJPHEART.00772.2010
P577
2010-12-30T00:00:00Z